Concepedia

Publication | Open Access

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

DOIFull Paper Access

1.7K

Citations

29

References

2013

Year

Michael Wang, Simon Rule, Peter Martin, André Goy, Rebecca Auer, Brad S. Kahl, Wojciech Jurczak, Ranjana H. Advani, Jorge Romaguera, Michael E. Williams,
New England Journal of Medicine

Abstract

Ibrutinib shows durable single-agent efficacy in relapsed or refractory mantle-cell lymphoma. (Funded by Pharmacyclics and others; ClinicalTrials.gov number, NCT01236391.)

References

YearCitations

Page 1